Skip to main content
Livermore
Livermore
ZHEN

Meros Investment Management, LP

SEC CIK
0001911372
Latest filing
Aug 14, 2026

The latest 13F from Meros Investment Management, LP covers Q2 2026 (filed Aug 14, 2026): 50 long positions worth $315.2M. The top 10 holdings make up 44.2% of the portfolio, and the largest is Ducommun Inc (DCO) at 7.0%. Livermore has 19 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
7
Est. +$36.1M
Added
22
Est. +$59.3M
Reduced
21
Est. −$37.2M
Sold out
9
Est. −$41.6M

Top 5 holdings

Share of this quarter's portfolio value

  1. DCODucommun Inc
    7.0%$21.9MHistory
  2. MGNIMagnite, Inc.
    6.0%$18.8MHistory
  3. WTTRSelect Water Solutions, Inc.
    5.8%$18.2MHistory
  4. ARHSArhaus, Inc.
    4.5%$14.2MHistory
  5. COHUCohu Inc
    4.5%$14.1MHistory

Share of portfolio

Top 5 holdings and the other 45 positions, by share of portfolio value

  1. DCO7.0%
  2. MGNI6.0%
  3. WTTR5.8%
  4. ARHS4.5%
  5. COHU4.5%
  6. Other 45 positions72.3%

Biggest buys

New and added positions, by estimated amount bought

  1. ALGTAllegiant Travel CO
    +$8.22MNewHistory
  2. HCSGHealthcare Services Group Inc
    +$7.11MNewHistory
  3. TATTTat Technologies Ltd
    +$6.65MNewHistory
  4. WERNWerner Enterprises Inc
    +$6.53MAddedHistory
  5. PLABPhotronics Inc
    +$6.51MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. ALGTAllegiant Travel CO
    +2.61 pp0.0% → 2.6%History
  2. HCSGHealthcare Services Group Inc
    +2.26 pp0.0% → 2.3%History
  3. WERNWerner Enterprises Inc
    +2.21 pp1.7% → 3.9%History
  4. TATTTat Technologies Ltd
    +2.11 pp0.0% → 2.1%History
  5. BJRIBJs RESTAURANTS INC
    +2.02 pp0.7% → 2.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. THRThermon Group Holdings, Inc.
    −$12.2MSold outHistory
  2. NVRIEnviri Corp
    −$7.40MReducedHistory
  3. SLPSimulations Plus, Inc.
    −$6.77MReducedHistory
  4. SHOEShoe Station Group Inc
    −$6.60MSold outHistory
  5. COHUCohu Inc
    −$6.30MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. THRThermon Group Holdings, Inc.
    −5.27 pp5.3% → 0.0%History
  2. NVRIEnviri Corp
    −3.31 pp5.3% → 2.0%History
  3. SHOEShoe Station Group Inc
    −2.86 pp2.9% → 0.0%History
  4. BBWBuild-A-Bear Workshop Inc
    −2.47 pp2.5% → 0.0%History
  5. PHRPhreesia, Inc.
    −2.24 pp2.2% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$315.2M
+$84.4M (+36.6%) vs. prior quarter
Positions
50
−2 vs. prior quarter
Top 10 concentration
44.2%
Top 10 as share of value
Turnover
28.9%
Q2 2026, one quarter
Average holding period
9.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

19 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $315.2M (Q2 2026)

Q4 2021: $136.7MQ1 2022: $126.3MQ2 2022: $107.8MQ3 2022: $97.0MQ4 2022: $169.3MQ1 2023: $175.8MQ2 2023: $201.6MQ3 2023: $183.6MQ4 2023: $210.8MQ1 2024: $223.7MQ2 2024: $211.5MQ3 2024: $221.0MQ4 2024: $223.3MQ1 2025: $170.3MQ2 2025: $210.7MQ3 2025: $234.2MQ4 2025: $252.2MQ1 2026: $230.7MQ2 2026: $315.2M
Q4 2021Q2 2026
13F filings of Meros Investment Management, LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202650$315.2MDCOMGNIWTTRvs. Q1 2026SEC
Q1 2026May 14, 202652$230.7MDCOWTTRNVRIvs. Q4 2025SEC
Q4 2025Feb 17, 202648$252.2MDCOMGNITHRvs. Q3 2025SEC
Q3 2025Nov 14, 202543$234.2MDCOPLYMMGNIvs. Q2 2025SEC
Q2 2025Aug 14, 202541$210.7MMGNIDCOPLYMvs. Q1 2025SEC
Q1 2025May 13, 202541$170.3MDCOPLABPLYMvs. Q4 2024SEC
Q4 2024Feb 14, 202540$223.3MMGNIDCOPLABvs. Q3 2024SEC
Q3 2024Nov 18, 202440$221.0MMGNIDCOTILEvs. Q2 2024SEC
Q2 2024Aug 15, 202439$211.5MMGNIDCOPLABvs. Q1 2024SEC
Q1 2024May 15, 202440$223.7MPLABTILEMGNIvs. Q4 2023SEC
Q4 2023Feb 15, 202442$210.8MPLABWNCDCOvs. Q3 2023SEC
Q3 2023Nov 14, 202336$183.6MPLABDCOWNCvs. Q2 2023SEC
Q2 2023Aug 11, 202336$201.6MPLABWNCMGNIvs. Q1 2023SEC
Q1 2023May 16, 202337$175.8MDCOWNCPLABvs. Q4 2022SEC
Q4 2022Feb 14, 202337$169.3MDCOWNCPLABvs. Q3 2022SEC
Q3 2022Nov 14, 202238$97.0MWNCPLABTILEvs. Q2 2022SEC
Q2 2022Aug 12, 202235$107.8MPLABMeridian Bioscience IncTILEvs. Q1 2022SEC
Q1 2022May 13, 202235$126.3MMeridian Bioscience IncPLABIINvs. Q4 2021SEC
Q4 2021Feb 16, 202239$136.7MPLABTILETLYS–SEC